{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:40:07Z","timestamp":1760823607044,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.jocn.2011.07.029","type":"journal-article","created":{"date-parts":[[2011,12,9]],"date-time":"2011-12-09T15:45:11Z","timestamp":1323445511000},"page":"107-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Overexpression of the Notch3 receptor in non-functioning pituitary tumours"],"prefix":"10.1016","volume":"19","author":[{"given":"Zengli","family":"Miao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifeng","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2011.07.029_b0005","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3171\/jns.1987.66.2.0244","article-title":"Hormone production in clinically nonfunctioning pituitary adenomas","volume":"66","author":"Black","year":"1987","journal-title":"J Neurosug"},{"key":"10.1016\/j.jocn.2011.07.029_b0010","first-page":"1089","article-title":"Clinical review 45: Clinically nonfunctioning pituitary adenomas","volume":"76","author":"Katzneson","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocn.2011.07.029_b0015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev.med.47.1.95","article-title":"Diagnosis and management of nonfunctioning pituitary tumors","volume":"47","author":"Greenman","year":"1996","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jocn.2011.07.029_b0020","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1017\/S0317167100042311","article-title":"Clinically non-functioning human pituitary adenomas","volume":"19","author":"Asa","year":"1992","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.jocn.2011.07.029_b0025","first-page":"798","article-title":"The cytogenesis and pathogenesis of pituitary adenomas","volume":"19","author":"Asa","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jocn.2011.07.029_b0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1677\/joe.0.1570177","article-title":"Current perspectives on the pathogenesis of clinically non-functioning pituitary tumors","volume":"157","author":"Gittoes","year":"1998","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jocn.2011.07.029_b0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1042-3680(02)00072-4","article-title":"Medical treatment of functional pituitary tumors","volume":"14","author":"Vance","year":"2003","journal-title":"Neurosurg Clin N Am"},{"key":"10.1016\/j.jocn.2011.07.029_b0040","doi-asserted-by":"crossref","first-page":"472","DOI":"10.7326\/0003-4819-129-6-199809150-00009","article-title":"Management of pituitary tumor","volume":"129","author":"Iian","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jocn.2011.07.029_b0045","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/jcp.20542","article-title":"Physiology and pathology of Notch signaling system","volume":"207","author":"Bianchi","year":"2006","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jocn.2011.07.029_b0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(00)80336-0","article-title":"Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane","volume":"90","author":"Blaumueller","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.jocn.2011.07.029_b0055","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/er.2006-0046","article-title":"Notch signaling in development and cancer","volume":"28","author":"Bolos","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jocn.2011.07.029_b0060","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0092-8674(95)90294-5","article-title":"Jagged: a mammalian ligand that activates Notch1","volume":"80","author":"Lindsell","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jocn.2011.07.029_b0065","doi-asserted-by":"crossref","first-page":"R273","DOI":"10.1016\/S0960-9822(03)00199-4","article-title":"Notch signaling: endocytosis makes delta signal better","volume":"13","author":"Le","year":"2003","journal-title":"Curr Biol"},{"key":"10.1016\/j.jocn.2011.07.029_b0070","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.1038\/sj.onc.1206758","article-title":"Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents","volume":"22","author":"Brian","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jocn.2011.07.029_b0075","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.284.5415.770","article-title":"Notch signaling: cell fate control and signal integration in development n1","volume":"284","author":"Artavan-Tsakonas","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jocn.2011.07.029_b0080","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/01.sla.0000189115.94847.f1","article-title":"The Notch signaling pathway is related to neurovascular progression of pancreatic cancer","volume":"242","author":"Buchler","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.jocn.2011.07.029_b0085","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/jnci\/92.16.1355","article-title":"Chromosome 19 translocation, overexpression of Notch3, and human lung cancer","volume":"92","author":"Dang","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jocn.2011.07.029_b0090","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.1158\/0008-5472.CAN-05-3610","article-title":"Notch3 gene amplification in ovarian cancer","volume":"66","author":"Park","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jocn.2011.07.029_b0095","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.emboj.7600996","article-title":"Notch3 and pre-TCR interaction unveils distinct NF-kappa B pathways in T-cell development and leukemia","volume":"25","author":"Vacca","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.jocn.2011.07.029_b0100","doi-asserted-by":"crossref","first-page":"10214","DOI":"10.1158\/0008-5472.CAN-05-0884","article-title":"Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and protemic analyses","volume":"65","author":"Moreno","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jocn.2011.07.029_b0105","first-page":"229","article-title":"Large scale screening for genes related to pathogenesis of pituitary carcinoma","volume":"20","author":"Song","year":"2001","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.jocn.2011.07.029_b0110","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.onc.1209074","article-title":"Notch3 signaling initiates choroid plexus tumor formation","volume":"25","author":"Dang","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.jocn.2011.07.029_b0115","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1158\/0008-5472.CAN-04-3132","article-title":"Dominant-negative Notch3 receptor inhibits mitogen activated protein kinase pathway and the growth of human lung cancers","volume":"65","author":"Haruki","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jocn.2011.07.029_b0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1471-4914(02)00003-5","article-title":"Notch, a unifying target in T cell acute lymphoblastic leukemia?","volume":"9","author":"Screpanti","year":"2003","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jocn.2011.07.029_b0125","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1093\/emboj\/19.13.3337","article-title":"Constitutive activation of NF-kB and T cell leukemia\/lymphoma in Notch3 transgenic mice","volume":"19","author":"Bellavia","year":"2000","journal-title":"EMBO J"},{"key":"10.1016\/j.jocn.2011.07.029_b0130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1586\/17446651.3.1.91","article-title":"Notch-Hes signaling in pituitary development","volume":"3","author":"Hojo","year":"2008","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.jocn.2011.07.029_b0135","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/path.2293","article-title":"Evidence of Notch pathway activation in the ectatic ducts of chronic pancreatitis","volume":"214","author":"Bhanot","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.jocn.2011.07.029_b0140","doi-asserted-by":"crossref","first-page":"21723","DOI":"10.1074\/jbc.M202224200","article-title":"Notch3 signaling in vascular smooth muscle cells induces c-FLIP expression via ERK\/MAPK activation. Resistance to Fas ligand-induced apoptosis","volume":"277","author":"Wang","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jocn.2011.07.029_b0145","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/sj.emboj.7601626","article-title":"Notch3 and the Notch3-upregulated RNA-binding protein HuD regulate Ikaros alternative splicing","volume":"26","author":"Bellavia","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.jocn.2011.07.029_b0150","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1227\/01.NEU.0000312715.01310.49","article-title":"Inhibition of NF kappaB reduces cellular viability in GH3 pituitary adenoma cells","volume":"62","author":"Vender","year":"2008","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jocn.2011.07.029_b0155","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.1038\/sj.onc.1206758","article-title":"Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents","volume":"22","author":"Nickoloff","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jocn.2011.07.029_b0160","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1158\/0008-5472.CAN-05-3054","article-title":"Aberrant activation of Notch signaling in human breast cancer","volume":"66","author":"Stylianou","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jocn.2011.07.029_b0165","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1042\/BJ20081625","article-title":"Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin\/gamma-secretase activity","volume":"420","author":"Riedle","year":"2009","journal-title":"Biochem J"},{"key":"10.1016\/j.jocn.2011.07.029_b0170","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1158\/0008-5472.CAN-07-1022","article-title":"Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers","volume":"67","author":"Konishi","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jocn.2011.07.029_b0175","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1158\/0008-5472.CAN-07-1022","article-title":"Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers","volume":"67","author":"Konishi","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jocn.2011.07.029_b0180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1200\/jco.2006.24.18_suppl.6585","article-title":"A phase I clinical trial of the notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia\/lymphoma (T-ALL) and other leukemias","volume":"24","author":"Deangelo","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586811005194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586811005194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:14:16Z","timestamp":1760822056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586811005194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0967586811005194"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2011.07.029","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overexpression of the Notch3 receptor in non-functioning pituitary tumours","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2011.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}